跳至主要内容
临床试验/CTIS2023-504641-32-00
CTIS2023-504641-32-00进行中(未招募)1 期

A geroscience approach to post-acute COVID-19 syndrome (PACS) by Diet and Exercise plus rapamycin or metformin to treat Frailty and restore immune functions: a randomized, single center clinical trial. - Gero-PACS

Azienda Ospedaliero Universitaria Di Modena0 个研究点目标入组 60 人开始时间: 2023年3月30日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Confirmed PACS diagnosis according to WHO definition by two consecutive clinical assessment, Previous hospital admission for Severe COVID Pneumonia, Age 40-80 years, Frailty or pre-frailty status performed with frailty phenotype criteria, Independently mobile, Able and willing to provide written consent.

排除标准

  • Previous or current use of metformin, Diabetes history or diagnosis at baseline, Transplant or cancer requiring chemotherapy, History of chronic kidney disease (eGFR<30 mil/min), Allergies to metformin or rapamycin, Female participant pregnant or breastfeeding, Baseline SPPB score <3, Life expectancy <6 months

研究者

发起方
Azienda Ospedaliero Universitaria Di Modena

相似试验

A geroscience approach to post-acute COVID-19... | 临床试验